5 Analysts Have This to Say About Immunocore Hldgs
Portfolio Pulse from Benzinga Insights
Immunocore Hldgs (NASDAQ:IMCR) has received 5 analyst ratings in the last quarter, with 2 being bullish and 3 somewhat bullish. There have been no indifferent, somewhat bearish, or bearish ratings. The average price target is $78.8, representing an implied upside from the current price of $46.94. This target has increased by 5.07% from the previous target of $75.00. Analysts typically review stocks quarterly or after major company updates, basing their ratings on financial predictions and company performance.
November 20, 2023 | 2:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Immunocore Hldgs has received positive analyst ratings, with an average price target of $78.8, indicating a potential upside from the current price of $46.94. The target has been raised from $75.00, showing increased confidence from analysts.
The unanimous positive ratings and the raised price target suggest that analysts see strong potential in IMCR. This optimism is likely to influence investor sentiment and could lead to a short-term increase in the stock price, especially as the target implies a significant upside.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100